Mutant PIK3CA-mediated pancreatic tumorigenesis and the response to PI3K pathway inhibition.

被引：1
|
作者：
Payne, Susan
Maher, Molly
Nguyen Tran
Van DeHey, Dana
Tyler, Foley
Yeuh, Alexander
Leystra, Alyssa A.
Pasch, Cheri
Clipson, Linda
Matkowskyj, Kristina
Deming, Dustin A.
机构：
[1] Univ Wisconsin, Carbone Canc Ctr, Madison, WI USA
[2] Univ Wisconsin, Dept Oncol, Madison, WI USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.e15273
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15273
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Oncogenic PIK3CA-driven mammary tumors frequently recur via PI3K pathway-dependent and PI3K pathway-independent mechanisms
    Liu, Pixu
    Cheng, Hailing
    Santiago, Stephanie
    Raeder, Maria
    Zhang, Fan
    Isabella, Adam
    Yang, Janet
    Semaan, Derek J.
    Chen, Changzhong
    Fox, Edward A.
    Gray, Nathanael S.
    Monahan, John
    Schlegel, Robert
    Beroukhim, Rameen
    Mills, Gordon B.
    Zhao, Jean J.
    NATURE MEDICINE, 2011, 17 (09) : 1116 - U122
  • [22] Allosteric PI3Kα Inhibition Overcomes On-target Resistance to Orthosteric Inhibitors Mediated by Secondary PIK3CA Mutations
    Varkaris, Andreas
    de la Cruz, Ferran Fece
    Martin, Elizabeth E.
    Norden, Bryanna L.
    Chevalier, Nicholas
    Kehlmann, Allison M.
    Leshchiner, Ignaty
    Barnes, Haley
    Ehnstrom, Sara
    Stavridi, Anastasia-Maria
    Yuan, Xin
    Kim, Janice S.
    Ellis, Haley
    Papatheodoridi, Alkistis
    Gunaydin, Hakan
    Danysh, Brian P.
    Parida, Laxmi
    Sanidas, Ioannis
    Ji, Yongli
    Lau, Kayao
    Wulf, Gerburg M.
    Bardia, Aditya
    Spring, Laura M.
    Isakoff, Steven J.
    Lennerz, Jochen K.
    Del Vecchio, Kathryn
    Pierce, Levi
    Pazolli, Ermira
    Getz, Gad
    Corcoran, Ryan B.
    Juric, Dejan
    CANCER DISCOVERY, 2024, 14 (02) : 227 - 239
  • [23] Stroma-driven resistance to PI3K/mTOR inhibition.
    Muranen, Taru
    MOLECULAR CANCER RESEARCH, 2020, 18 (10) : 16 - 16
  • [24] PIK3CA regulates development of diabetes retinopathy through the PI3K/Akt/mTOR pathway
    Guan, Ruijuan
    Kang, Zefeng
    Li, Ling
    Yan, Xin
    Gao, Tianpeng
    PLOS ONE, 2024, 19 (01):
  • [25] Selective PI3K inhibition in wild type and PIK3CA mutated human gastrointestinal cancer
    Mueller, A.
    Bachmann, E.
    Linnig, M.
    Khillimberger, K.
    Galle, P. R.
    Moehler, M.
    ONKOLOGIE, 2011, 34 : 246 - 246
  • [26] CDK 4/6 Inhibitors Sensitize PIK3CA Mutant Breast Cancer to PI3K Inhibitors
    Vora, Sadhna R.
    Juric, Dejan
    Kim, Nayoon
    Mino-Kenudson, Mari
    Huynh, Tiffany
    Costa, Carlotta
    Lockerman, Elizabeth L.
    Pollack, Sarah F.
    Liu, Manway
    Li, Xiaoyan
    Lehar, Joseph
    Wiesmann, Marion
    Wartmann, Markus
    Chen, Yan
    Cao, Z. Alexander
    Pinzon-Ortiz, Maria
    Kim, Sunkyu
    Schlegel, Robert
    Huang, Alan
    Engelman, Jeffrey A.
    CANCER CELL, 2014, 26 (01) : 136 - 149
  • [27] Inhibition of the PI3K/AKT/mTOR pathway in pancreatic cancer: is it a worthwhile endeavor?
    Ouissam, Al Jarroudi
    Hind, Chibani
    Aziz, Brahmi Sami
    Said, Afqir
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2024, 16
  • [28] Horizontal Combination of MEK and PI3K/mTOR Inhibition in BRAF Mutant Tumor Cells with or without Concomitant PI3K Pathway Mutations
    Rittler, Dominika
    Molnar, Eszter
    Baranyi, Marcell
    Garay, Tamas
    Hegedus, Luca
    Aigner, Clemens
    Tovari, Jozsef
    Timar, Jozsef
    Hegedus, Balazs
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (20) : 1 - 18
  • [29] mTORC1 Inhibition Is Required for Sensitivity to PI3K p110α Inhibitors in PIK3CA-Mutant Breast Cancer
    Elkabets, Moshe
    Vora, Sadhna
    Juric, Dejan
    Morse, Natasha
    Mino-Kenudson, Mari
    Muranen, Taru
    Tao, Jessica
    Campos, Ana Bosch
    Rodon, Jordi
    Ibrahim, Yasir H.
    Serra, Violeta
    Rodrik-Outmezguine, Vanessa
    Hazra, Saswati
    Singh, Sharat
    Kim, Phillip
    Quadt, Cornelia
    Liu, Manway
    Huang, Alan
    Rosen, Neal
    Engelman, Jeffrey A.
    Scaltriti, Maurizio
    Baselga, Jose
    SCIENCE TRANSLATIONAL MEDICINE, 2013, 5 (196)
  • [30] Activation of the MACC1/PIM/cMyc axis confers resistance to PI3K/mTOR inhibition in PIK3CA mutant NSCLC
    Moore, Gillian
    Elbai, Samira
    Heavey, Susan
    Finn, Stephen
    O'Neill, Michael
    Gately, Kathy
    MOLECULAR CANCER RESEARCH, 2020, 18 (10) : 48 - 48
12345